Important information

  • The Fund invests in healthcare companies throughout the world.
  • Investors should note the risk of investing in healthcare companies, currency exchange risk, equities risk, volatility risk, sector based and concentrated funds risk, general investment risk, and risk relating to those share classes denominated/dealt in a different currency than the base currency of the Fund.
  • Financial derivative instruments (FDI) may be used for efficient portfolio management purposes or to hedge or reduce the overall risk of investments.  Risks associated with FDI include counterparty/credit risk, liquidity risk, valuation risk, volatility risk and over-the-counter transaction risk. The leverage element/component of a FDI can result in a loss significantly greater than the amount invested in the FDI by the Fund. Exposure to FDI may lead to a high risk of significant loss by the Fund.
  • The value of the Fund can be volatile and could go down substantially.
  • Investors should not base their investment decision on this material alone.
  • Invesco Global Health Care Fund


NAV (17/08/2017)

124.8900 USD

12 months
Low High
106.4900 131.2900

Why This Fund

  • The fund has a long track record (fund launch in March 1994) with an aim of providing long-term capital growth from investments in global healthcare equites
  • The US-based investment team has in-depth knowledge of companies engaged in pharmaceuticals, biotechnology, healthcare services and medical technology and supplies worldwide (largely United States)
  • Distribution shares are available for investors who want to receive potential cash income (if any).

Fund performance chart

Cumulative Performance

Last update date: 30/06/2017
  YTD 3M 6M 1Y 3Y 5Y Since Launch~
Share Class 13.12% 4.35% 13.12% 11.00% 7.68% 71.09% 1,212.42%
Index^ 15.96% 6.93% 15.96% 9.83% 22.79% 100.27% 872.96%

Calendar Year Performance

Last update date: 31/12/2016
2016 2015 2014 2013 2012
Share Class -13.51% 1.02% 19.31% 37.53% 16.61%
Index^ -6.81% 6.60% 18.10% 36.27% 17.54%

Dividend Report+

  • Display as
  • TWELVE

Aims to pay dividend on monthly/ quarterly/ semi-annual/ annual basis. Dividend is not guaranteed. For Fixed Distribution Shares, Gross Income Shares and Monthly Distribution-1 Shares, dividend may be paid out of the capital. Please refer to Note 1 and/ or Note 2 of the "Important Information".

Record Date (DD/MM/YY) Rate / Share (USD) Price on Record Date (USD) Annualized Dividend (%)
30/11/2016 0.0000 114.77 0.00
30/11/2015 0.0000 130.89 0.00

^ Reference Index: MSCI World Healthcare ND

+ Annualized dividend (%) = (Rate/Share X Frequency) ÷ Price on record date. Upon dividend distribution, the fund's net asset value may fall on the ex-dividend date. For Frequency, Monthly = 12; Quarterly = 4; Semi-Annually = 2; Annually =1. All distributions below USD 50 in value (or its equivalent) will be automatically applied in the purchase of further shares of the same class. Positive distribution yield does not imply a positive return.

~For share class's launch date, please refer to Fund Details section.

Fund Objective

Aims at achieving long-term capital growth by investing in healthcare companies throughout the world. These include companies operating in the healthcare sectors of pharmaceuticals, biotechnology, healthcare services and medical technology and supplies.

Key Facts

Launch Date 03/03/1994
Fund Size USD 483.29mn (as of 30/06/2017)
Management Fee 2.00%
Minimum investment USD 1,500
Initial Charge (up to) 5.00%
Fund Manager Derek Taner, Henry Wu
Bloomberg Code INVHEDA ID
ISIN Code IE0003824293
IVRS Code 601

Bulletin Board

How To Buy


Important information

Investment involves risks. Past performance is not indicative of future performance. Investors should read the relevant prospectus for details, including the risk factors and product features. This material has not been reviewed by the Securities and Futures Commission and is issued by Invesco Asset Management Asia Limited (景順投資管理亞洲有限公司). 

All data (including fund and reference index performances) is sourced from Invesco unless otherwise stated.

Performance of the share class is calculated based on NAV to NAV, gross income re-invested in share class currency.